Crossref
Neoadjuvant immunotherapy in melanoma — from immune checkpoint discovery to a new treatment paradigm
Nowotwory. Journal of Oncology · 29.04.2026 · 76 (2) · 61-63
DOI: 10.5603/njo.110667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nowotwory. Journal of Oncology, online erschienen am 29.04.2026. Verfasst von Roger Olofsson Bagge und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bagge, R. O., & Rutkowski, P. (2026). Neoadjuvant immunotherapy in melanoma — from immune checkpoint discovery to a new treatment paradigm. Nowotwory. Journal of Oncology, 76(2), 61-63. https://doi.org/10.5603/njo.110667
Vancouver
Bagge RO, Rutkowski P. Neoadjuvant immunotherapy in melanoma — from immune checkpoint discovery to a new treatment paradigm. Nowotwory. Journal of Oncology. 2026;76(2):61-63. doi:10.5603/njo.110667
BibTeX
@article{Bagge2026,
author = {Bagge, Roger Olofsson and Rutkowski, Piotr},
title = {Neoadjuvant immunotherapy in melanoma — from immune checkpoint discovery to a new treatment paradigm},
journal = {Nowotwory. Journal of Oncology},
year = {2026},
volume = {76},
number = {2},
pages = {61--63},
doi = {10.5603/njo.110667}
}
EUVIMED